342 related articles for article (PubMed ID: 19763438)
1. Activated epidermal growth factor receptor in ovarian cancer.
Hudson LG; Zeineldin R; Silberberg M; Stack MS
Cancer Treat Res; 2009; 149():203-26. PubMed ID: 19763438
[No Abstract] [Full Text] [Related]
2. Epidermal growth factor receptor signaling and the invasive phenotype of ovarian carcinoma cells.
Alper O ; Bergmann-Leitner ES; Bennett TA; Hacker NF; Stromberg K; Stetler-Stevenson WG
J Natl Cancer Inst; 2001 Sep; 93(18):1375-84. PubMed ID: 11562388
[TBL] [Abstract][Full Text] [Related]
3. EGF-receptor tyrosine kinase and 12-lipoxygenase activity regulate expression of 12-lipoxygenase in human tumor cells.
Hagmann W; Borgers S
Adv Exp Med Biol; 1997; 407():9-14. PubMed ID: 9321925
[No Abstract] [Full Text] [Related]
4. Oncogenic epidermal growth factor receptor up-regulates multiple elements of the tissue factor signaling pathway in human glioma cells.
Magnus N; Garnier D; Rak J
Blood; 2010 Aug; 116(5):815-8. PubMed ID: 20462964
[TBL] [Abstract][Full Text] [Related]
5. Molecular biology in head and neck cancer.
Hitt R; Echarri MJ
Clin Transl Oncol; 2006 Nov; 8(11):776-9. PubMed ID: 17134964
[TBL] [Abstract][Full Text] [Related]
6. TGFβ and EGF signaling orchestrates the AP-1- and p63 transcriptional regulation of breast cancer invasiveness.
Sundqvist A; Vasilaki E; Voytyuk O; Bai Y; Morikawa M; Moustakas A; Miyazono K; Heldin CH; Ten Dijke P; van Dam H
Oncogene; 2020 May; 39(22):4436-4449. PubMed ID: 32350443
[TBL] [Abstract][Full Text] [Related]
7. ErbB-2 signals through Plexin-B1 to promote breast cancer metastasis.
Worzfeld T; Swiercz JM; Looso M; Straub BK; Sivaraj KK; Offermanns S
J Clin Invest; 2012 Apr; 122(4):1296-305. PubMed ID: 22378040
[TBL] [Abstract][Full Text] [Related]
8. The cell surface glycoprotein CUB domain-containing protein 1 (CDCP1) contributes to epidermal growth factor receptor-mediated cell migration.
Dong Y; He Y; de Boer L; Stack MS; Lumley JW; Clements JA; Hooper JD
J Biol Chem; 2012 Mar; 287(13):9792-9803. PubMed ID: 22315226
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor and ionizing radiation up-regulate the DNA repair genes XRCC1 and ERCC1 in DU145 and LNCaP prostate carcinoma through MAPK signaling.
Yacoub A; McKinstry R; Hinman D; Chung T; Dent P; Hagan MP
Radiat Res; 2003 Apr; 159(4):439-52. PubMed ID: 12643788
[TBL] [Abstract][Full Text] [Related]
10. The oncogenic potential of a bystander.
Lang F; Föller M
Cancer Biol Ther; 2009 Aug; 8(15):1478-9. PubMed ID: 19556881
[No Abstract] [Full Text] [Related]
11. Regulation of gene expression in ovarian cancer cells by luteinizing hormone receptor expression and activation.
Cui J; Miner BM; Eldredge JB; Warrenfeltz SW; Dam P; Xu Y; Puett D
BMC Cancer; 2011 Jun; 11():280. PubMed ID: 21711548
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells.
Baba T; Convery PA; Matsumura N; Whitaker RS; Kondoh E; Perry T; Huang Z; Bentley RC; Mori S; Fujii S; Marks JR; Berchuck A; Murphy SK
Oncogene; 2009 Jan; 28(2):209-18. PubMed ID: 18836486
[TBL] [Abstract][Full Text] [Related]
13. Ligand activation of overexpressed epidermal growth factor receptors transforms NIH 3T3 mouse fibroblasts.
Riedel H; Massoglia S; Schlessinger J; Ullrich A
Proc Natl Acad Sci U S A; 1988 Mar; 85(5):1477-81. PubMed ID: 3257824
[TBL] [Abstract][Full Text] [Related]
14. EGF/ErbB receptor family in ovarian cancer.
Maihle NJ; Baron AT; Barrette BA; Boardman CH; Christensen TA; Cora EM; Faupel-Badger JM; Greenwood T; Juneja SC; Lafky JM; Lee H; Reiter JL; Podratz KC
Cancer Treat Res; 2002; 107():247-58. PubMed ID: 11775453
[TBL] [Abstract][Full Text] [Related]
15. EGF prevents the neuroendocrine differentiation of LNCaP cells induced by serum deprivation: the modulator role of PI3K/Akt.
Martín-Orozco RM; Almaraz-Pro C; Rodríguez-Ubreva FJ; Cortés MA; Ropero S; Colomer R; López-Ruiz P; Colás B
Neoplasia; 2007 Aug; 9(8):614-24. PubMed ID: 17898861
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of EGF receptor regulation in breast cancer cells.
Chrysogelos SA; Yarden RI; Lauber AH; Murphy JM
Breast Cancer Res Treat; 1994; 31(2-3):227-36. PubMed ID: 7881101
[TBL] [Abstract][Full Text] [Related]
17. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
[No Abstract] [Full Text] [Related]
18. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
Liang Y; Bollen AW; Aldape KD; Gupta N
BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor, but not c-erbB-2, activation prevents lactogenic hormone induction of the beta-casein gene in mouse mammary epithelial cells.
Hynes NE; Taverna D; Harwerth IM; Ciardiello F; Salomon DS; Yamamoto T; Groner B
Mol Cell Biol; 1990 Aug; 10(8):4027-34. PubMed ID: 2196443
[TBL] [Abstract][Full Text] [Related]
20. Caveolin-1 regulates EGFR signaling in MCF-7 breast cancer cells and enhances gefitinib-induced tumor cell inhibition.
Agelaki S; Spiliotaki M; Markomanolaki H; Kallergi G; Mavroudis D; Georgoulias V; Stournaras C
Cancer Biol Ther; 2009 Aug; 8(15):1470-7. PubMed ID: 19483462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
